FDA Panel Rejects Use of MDMA for Treatment of PTSD

An independent advisory panel of the Food and Drug Administration rejected the use of MDMA-assisted therapy for post-traumatic stress disorder on Tuesday, highlighting the unparalleled regulatory challenges of a novel therapy using an illegal drug commonly known as Ecstasy. Before the vote, members of the panel raised concerns about the designs of the two studies…

Read More

FDA Panel Weights MDMA Therapy for PTSD

The Food and Drug Administration is weighing whether to approve the use of MDMA, also known as Ecstasy, for treatment of post-traumatic stress disorder. An independent advisory panel of experts will review studies on Tuesday and is expected to vote on whether the treatment would be effective and whether its benefits outweigh the risks. The…

Read More

FDA Approves Antibiotic to Treat Urinary Infections

The Food and Drug Administration on Wednesday approved the sale of an antibiotic for the treatment of urinary tract infections in women, giving U.S. health providers a powerful new tool to combat a common infection that is increasingly unresponsive to the existing suite of antimicrobial drugs. The drug, pivmecillinam, has been used in Europe for…

Read More

Wegovy Approved By FDA to Reduce Heart Attack Risk

Wegovy, the blockbuster weight loss drug, is now approved for a new use: reducing the risk of heart attacks, strokes and cardiovascular-related death in adults who have heart disease and are overweight or have obesity. The new indication, which the Food and Drug Administration announced on Friday, will pave the way for even more patients…

Read More